What is Gilenya?
Gilenya (fingolimod) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS). It helps reduce flare-ups and slow disease progression by preventing immune cells from attacking the nervous system.
Efficacy And Statistics Of Gilenya
Clinical Trial Data
- FREEDOMS Trial (Phase III, 2-year study)
- Annual Relapse Rate (ARR):
- Gilenya 0.5 mg: 0.18 (54% reduction vs. placebo)
- Placebo: 0.40
- Disability Progression (3-month confirmed):
- Gilenya: 17.7%
- Placebo: 24.1% (30% reduction)
- MRI Results:
- Reduction in new/enlarging T2 lesions: 74% vs. placebo
- Reduction in Gd-enhancing lesions: 82% vs. placebo
- Annual Relapse Rate (ARR):
- FREEDOMS II Trial (Phase III, 2-year study)
- ARR Reduction: 48% vs. placebo
- Disability Progression:
- Gilenya: 16.6%
- Placebo: 20.6%
- MRI Results:
- 50–70% fewer new lesions compared to placebo
- TRANSFORMS Trial (Phase III, 1-year study, Compared to Avonex)
- ARR Reduction:
- Gilenya: 0.16
- Avonex (interferon beta-1a): 0.33
- 52% reduction in relapses vs. Avonex
- MRI Results:
- 30–40% reduction in brain volume loss compared to Avonex
- ARR Reduction:
- LONG-TERM EXTENSION STUDIES
- ARR in long-term follow-up (~8 years): 0.16–0.20
- Disability Progression:
- Confirmed disability progression remained low (~18–22% over 6 years)
- Brain Volume Loss: Slower rate of atrophy in long-term users
Real-World Data & Observational Studies
- Meta-analysis of Gilenya users (~5,000 patients):
- Relapse reduction: 40–60%
- Lower hospitalization rates vs. injectables
- Improved quality of life scores

What Are The Side Effects Of Gilenya?
1. Common Side Effects (≥10% of Patients)
Side Effect | Incidence (%) | Notes |
---|---|---|
Headache | ~25% | Most common side effect |
Cough | ~15% | Usually mild but can persist |
Diarrhea | ~12% | May resolve over time |
Back pain | ~10% | Can be managed with physical therapy or pain relievers |
Fatigue | ~10% | Common in MS patients, worsened by Gilenya |
Flu-like symptoms | ~10% | Resembling mild viral infection |
Liver enzyme elevation (ALT/AST) | 8–15% | Usually mild but monitoring needed |
2. Serious Side Effects
a) Heart Issues (Bradycardia & Arrhythmia)
- First-dose effect: Gilenya can slow heart rate within 4–6 hours after the first dose.
- Bradycardia incidence:
- 3–4 bpm drop in most patients
- Severe cases (~4%): HR can drop below 40 bpm
- Risk of heart block (AV block) in ~0.2% of patients
- Monitoring required:
- ECG before and after the first dose
- 6-hour observation period
- High-risk patients (e.g., preexisting heart conditions) may need overnight monitoring
b) Increased Risk of Infections
- Lymphocyte count drops by ~73% → Higher risk of viral, bacterial and fungal infections
- Serious infections (~4%): Pneumonia, bronchitis, herpes and fungal infections
- Rare cases of fatal infections reported
Precautions:
- Vaccinations recommended before starting treatment (e.g., varicella/zoster vaccine)
- Avoid live vaccines during and 2 months after treatment
c) Macular Edema (Swelling in the Eye)
- Seen in ~0.4–1% of patients
- More common in diabetics and those with a history of uveitis
- Symptoms:
- Blurred vision
- Distorted central vision
- Increased sensitivity to light
- Monitoring:
- Eye exam before starting treatment
- Follow-up exam at 3–4 months after initiation
d) Liver Toxicity (Hepatotoxicity)
- Incidence:
- Mild liver enzyme elevation (ALT/AST) in ~8–15% of patients
- Severe liver injury rare (~1 in 10,000 cases)
- Symptoms of liver damage:
- Jaundice (yellowing of skin/eyes)
- Dark urine
- Nausea/vomiting
- Monitoring:
- Liver function tests before treatment and every 3 months after starting
e) Progressive Multifocal Leukoencephalopathy (PML)
- Rare but serious viral brain infection
- Cases reported in long-term use (1 in ~10,000 patients)
- Symptoms:
- Cognitive decline
- Weakness
- Vision problems
Precaution:
- Regular MRI monitoring
f) Blood Pressure Increases
- Average increase:
- 3–4 mmHg systolic BP over 1 year
- Risk of developing hypertension (~8%)
- Regular BP monitoring needed
g) Respiratory Issues
- Lung function decline (~3–5% reduction in FEV1)
- Some patients develop shortness of breath or cough
- More common in those with asthma or COPD
h) Skin Cancers & Lymphoma Risk
- Basal Cell Carcinoma (~1–2%)
- Melanoma & Squamous Cell Carcinoma (~0.4–1%)
- Lymphoma risk slightly elevated (~0.1%)
Precaution:
- Regular skin exams
- Sun protection recommended
3. Warnings & Precautions
Condition | Risk | Monitoring Required |
---|---|---|
Pregnancy (Fetal Harm) | High | Use contraception during and 2 months after stopping |
Heart Conditions | High | ECG monitoring before & after first dose |
Diabetes/Uveitis (Eye Risk) | High | Regular eye exams |
Severe Infections Risk | High | Blood tests for immune function |
What Are The Costs Of Gilenya?
Canada
- Annual Cost: About $33,000 CAD per year.
- Insurance Coverage: Much of the cost can be reimbursed through private and group health plans for people who meet the prescribing criteria and through provincial drug programs for those who qualify.
Germany
- Price: As of February 14, 2025, the price for a 98-capsule pack of Gilenya 0.5 mg is about €5,348.63, equating to about €54.58 per capsule.
- Insurance Coverage: In Germany Gilenya is covered by statutory health insurance, which typically covers a significant portion of the cost for eligible patients.
United States
- Retail Price: About $11,204 for a 30-capsule supply of 0.5 mg capsules, equating to about $373 per capsule.
- Generic Availability: Generic versions are available with prices around $7.39 per 0.5 mg capsule for an 84-capsule supply.
Turkey
- Price: As of January 31, 2025, a box of Gilenya 0.5 mg containing 28 capsules is priced at 985.67 TL.
You can find details about another common MS drugs Kesimpta in below:
What Are The Dosages Of Gilenya?
Dosage for Multiple Sclerosis (MS)
- Initial Dose (First Dose):
- 0.5 mg once daily, ususally after the first dose is monitored for heart-related side effects.
- ECG monitoring is required for 6 hours after the first dose to observe heart rate changes.
- Maintenance Dose (After First Dose):
- 0.5 mg once daily.
- Taken orally with or without food.
Dosage Considerations:
- Renal Impairment (Kidney Issues):
- Dose adjustments may be needed for those with severe kidney impairment.
- Liver Impairment:
- Caution is required for patients with liver issues and liver function tests should be monitored.
Switching from Other Medications:
- If switching from injectable therapies (e.g., interferons), doctors may prefer to start Gilenya after a gap to minimize interactions.
Note:
- It’s important to follow the prescribed dosage by a doctor.
- If a dose is missed; it should be taken as soon as remembered but skipping the dose and taking the next dose at the usual time is generally recommended if it’s too close to the next dose.
How To Take Gilenya?
1. Dosage
- Initial Dose: Take 0.5 mg once daily starting with the first dose.
- Maintenance Dose: After the first dose, continue taking 0.5 mg once daily.
2. How to Take Gilenya
- Oral Administration: Gilenya comes in capsule form. Take it by mouth.
- With or Without Food: Gilenya can be taken either with or without food. The absorption of the medication is not significantly effected by meals.
- Swallow Whole: Do not crush or chew the capsules. Swallow them whole with a glass of water.
3. Special Considerations
- First Dose Monitoring:
- After the first dose, you’ll need to be monitored for heart rate changes for 6 hours.
- ECG monitoring is required to check for bradycardia (slow heart rate).
- Heart rate monitoring is important because it can decrease significantly after the first dose.
- Missed Dose:
- If you miss a dose; take it as soon as you remember unless it’s almost time for your next dose.
- In that case; skip the missed dose and resume your regular schedule.
- Missed Doses for 14 Days or More: If you have missed Gilenya for 14 days or more, you may need to restart the first-dose monitoring.
4. Liver and Kidney Health
- Liver Monitoring: Liver function tests should be done regularly. Avoid Gilenya if you have severe liver problems.
- Kidney Health: For those with kidney impairment, dose adjustments may be required.
5. Alcohol and Grapefruit
- Avoid drinking grapefruit juice or consuming large amounts of grapefruit while on Gilenya. This can interfere with how the medication is processed in your body.

Advices For Gilenya Users
1. First Dose Precautions
- Your first dose must be taken under medical supervision with heart monitoring for at least 6 hours.
- Gilenya can lower heart rate (bradycardia) after the first dose.
- If switching from another MS medication follow your doctor’s guidance on timing.
2. Taking Gilenya Safely
- Take one capsule (0.5 mg) daily at the same time every day.
- Do not skip doses. If you miss a dose for more than 14 days, contact your doctor. You may need to restart under supervision.
- Do not chew or crush the capsule; swallow it whole with water.
3. Infection Risk & Immune System Care
- Gilenya suppresses the immune system, increasing the risk of infections.
- Avoid sick people and crowded places during flu season.
- Check with your doctor before getting vaccinations live vaccines should be avoided during and 2 months after stopping treatment.
4. Eye Health Monitoring
- Gilenya can lead to macular edema (swelling in the retina).
- Get an eye exam before starting and repeat it 3–4 months later.
- If you notice blurred vision, dark spots or sensitivity to light, contact with your doctor immediately.
5. Liver & Kidney Monitoring
- Gilenya can effect liver function so liver tests should be done before and during treatment.
- Watch for symptoms of liver problems:
- Yellow skin/eyes (jaundice)
- Dark urine
- Unexplained nausea or fatigue
6. Pregnancy & Birth Control
- Gilenya can harm an unborn baby. Use effective birth control while taking it and for 2 months after stopping.
- If planning pregnancy discuss alternatives with your doctor.
7. Blood Pressure & Heart Care
- Gilenya can increase blood pressure. Regular blood pressure checks are advised.
- Avoid excessive caffeine or alcohol because of can worsen heart issues.
8. Stopping Gilenya Safely
- Never stop Gilenya suddenly. This can worsen MS symptoms (rebound effect).
- Your doctor will gradually taper or transition you to another medication if needed.
Final Advice
✅ Follow up with your neurologist regularly
✅ Stick to routine check-ups (heart, liver, eyes and blood tests)
✅ Maintain a healthy lifestyle (exercise, balanced diet, stress management)
✅ Report any unusual symptoms immediately
We wish a healthy and happy life to you. Also you can find a detailed comparison of most common MS treatment drugs in below: